Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chubb
Fuji
Baxter
Argus Health
Julphar
US Department of Justice
Federal Trade Commission
Queensland Health

Generated: January 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pirarubicin

« Back to Dashboard

US Patents for Pirarubicin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pirarubicin ➤ Sign Up Reduction of anthracycline induced cardiotoxicity New York University (New York, NY) ➤ Sign Up
Pirarubicin ➤ Sign Up Device for treating cancer and non-malignant tumors and methods Zomed International (Mountain View, CA) ➤ Sign Up
Pirarubicin ➤ Sign Up 1,4-dihydropyridines for application in combatting resistance to drugs BYK Gulden Lomberg Chemische Fabrik GmbH (Konstanz, DE) ➤ Sign Up
Pirarubicin ➤ Sign Up Methods and compositions for the treatment of a host with a cellular proliferative disease Matrix Pharmaceutical, Inc. (Menlo Park, CA) ➤ Sign Up
Pirarubicin ➤ Sign Up Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine biological barriers Marine Polymer Technologies, Inc. (Danvers, MA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Pirarubicin

Drugname Country Document Number Estimated Expiration Related US Patent
Pirarubicin Canada 1337590 2008-01-27 ➤ Sign Up
Pirarubicin Austria 180649 2013-11-08 ➤ Sign Up
Pirarubicin Austria 253871 2013-11-08 ➤ Sign Up
Pirarubicin Austria 352263 2013-11-08 ➤ Sign Up
Pirarubicin Austria 431108 2013-11-08 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Julphar
Baxter
US Army
Argus Health
AstraZeneca
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.